Suppression of Ras-stimulated transformation by the JNK signal transduction pathway

Genes and Development

Volumn 17, Issue 5, 2003, Pages 629-637

  Kennedy, Norman J ^a   Sluss, Hayla K ^a   Jones, Stephen N ^a   Bar Sagi, Dafna ^b   Flavell, Richard A ^c   Davis, Roger J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cancer; JNK; MAP kinase; Ras; Tumor suppressor

Indexed keywords

STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; GENE REPRESSION; GENETIC COMPLEMENTATION; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; FIBROBLASTS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS, EXPERIMENTAL; RAS PROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0037337694     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1062903     Document Type: Article

References (49)

1. Behrens, A., Jochum, W., Sibilia, M., and Wagner, E.F. 2000. Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene 19: 2657-2663.
2. Bennett, B.L., Sasaki, D.T., Murray, B.W., O'Leary, E.C., Sakata, S.T., Xu, W., Leisten, J.C., Motiwala, A., Pierce, S., Satoh, Y., et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. 98: 13681-13686.
3. Bos, J.L. 1989. Ras oncogenes in human cancer: A review. Cancer Res. 49: 4682-4689.
4. Bost, F., McKay, R., Bost, M., Potapova, O., Dean, N.M., and Mercola, D. 1999. The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells. Mol. Cell. Biol. 19: 1938-1949.
5. Clark, G.J., Cox, A.D., Graham, S.M., and Der, C.J. 1995. Biological assays for Ras transformation. Methods Enzymol. 255: 395-412.
6. Danos, O. and Mulligan, R.C. 1988. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. 85: 6460-6464.
7. Datta, S.R., Brunet, A., and Greenberg, M.E. 1999. Cellular survival: A play in three Akts. Genes & Dev. 13: 2905-2927.
8. Davis, R.J. 2000. Signal transduction by the INK group of MAP kinases. Cell 103: 239-252.
9. Debies, M.T. and Welch, D.R. 2001. Genetic basis of human breast cancer metastasis. J. Mammary Gland Biol. Neoplasia. 6: 441-451.
10. Evan, G.I. and Vousden, K.H. 2001. Proliferation, cell cycle, and apoptosis in cancer. Nature 411: 342-348.
11. Ganiatsas, S., Kwee, L., Fujiwara, Y., Perkins, A., Ikeda, T., Labow, M.A., and Zon, L.I. 1998. SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc. Natl. Acad. Sci. 95:6881-6886.
12. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S.A. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119: 493-501.
13. Gratzner, H.G. 1982. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 218: 474-475.
14. Gross, A., McDonnell, J.M., and Korsmeyer, S.J. 1999. BCL-2 family members and the mitochondria in apoptosis. Genes & Dev. 13: 1899-1911.
15. Harvey, M., Sands, A.T., Weiss, R.S., Hegi, M.E., Wiseman, R.W., Pantazis, P., Giovanella, B.C., Tainsky, M.A., Bradley, A., and Donehower, L.A. 1993. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8: 2457-2467.
16. Hess, P., Pihan, G., Sawyers, C.L., Flavell, R.A., and Davis, R.J. 2002. Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts. Nat. Genet. 32: 201-205.
17. Johnson, R., Spiegelman, B., Hanahan, D., and Wisdom, R. 1996. Cellular transformation and malignancy induced by ras require c-jun. Mol. Cell. Biol. 16: 4504-4511.
18. Joneson, T. and Bar-Sagi, D. 1999. Suppression of Ras-induced apoptosis by the Rac GTPase. Mol. Cell. Biol. 19: 5892-5901.
19. Kim, H.L., Griend, D.J., Yang, X., Benson, D.A., Dubauskas, Z., Yoshida, B.A., Chekmareva, M.A., Ichikawa, Y., Sokoloff, M.H., Zhan, P., et al. 2001. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res. 61: 2833-2837.
20. Kuan, C.Y., Yang, D.D., Samanta Roy, D.R., Davis, R.J., Rakic, P., and Flavell, R.A. 1999. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22: 667-676.
21. Macleod, K.F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes & Dev. 9: 935-944.
22. Maehama, T., Taylor, G.S., and Dixon, J.E. 2001. PTEN and myotubularin: Novel phosphoinositide phosphatases. Annu. Rev. Biochem. 70: 247-279.
23. Morgenstern, J.P. and Land, H. 1990. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18: 3587-3596.
24. Nakano, K. and Vousden, K.H. 2001. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7: 683-694.
25. Nishina, H., Fischer, K.D., Radvanyi, L., Shahinian, A., Hakem, R., Rubie, E.A., Bernstein, A., Mak, T.W., Woodgett, J.R., and Penninger, J.M. 1997. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385: 350-353.
26. Pear, W.S., Nolan, G.P., Scott, M.L., and Baltimore, D. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. 90: 8392-8396.
27. Potapova, O., Haghighi, A., Bost, F., Liu, C., Birrer, M.J., Gjerset, R., and Mercola, D. 1997. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem. 272: 14041-14044.
28. Potapova, O., Gorospe, M., Bost, F., Dean, N.M., Gaarde, W.A., Mercola, D., and Holbrook, N.J. 2000. c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells. J. Biol. Chem. 275:24767-24775.
29. Raingeaud, J., Gupta, S., Rogers, J.S., Dickens, M., Han, J., Ulevitch, R.J., and Davis, R.J. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270: 7420-7426.
30. Sabapathy, K., Jochum, W., Hochedlinger, K., Chang, L., Karin, M., and Wagner, E.F. 1999. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech. Dev. 89:115-124.
31. Sherr, C.J. and DePinho, R.A. 2000. Cellular senescence: Mitotic clock or culture shock? Cell 102: 407-410.
32. Soengas, M.S., Alarcon, R.M., Yoshida, H., Giaccia, A.J., Hakem, R., Mak, T.W., and Lowe, S.W. 1999. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284:156-159.
33. Soengas, M.S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J.G., Gerald, W.L., Lazebnik, Y.A., et al. 2001. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409: 207-211.
34. Su, G.H., Hilgers, W., Shekher, M.C., Tang, DJ., Yeo, C.J., Hruban, R.H., and Kern, S.E. 1998. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res. 58: 2339-2342.
35. Su, G.H., Song, J.J., Repasky, E.A., Schutte, M., and Kern, S.E. 2002. Mutation rate of MAP2K4/MKK4 in breast carcinoma. Hum. Mutat. 19: 81.
36. Teng, D.H., Perry III, W.L., Hogan, J.K., Baumgard, M., Bell, R., Berry, S., Davis, T., Frank, D., Frye, C., Hattier, T., et al. 1997. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res. 57: 4177-4182.
37. Tournier, C., Hess, P., Yang, D.D., Xu, J., Turner, T.K., Nimnual, A., Bar-Sagi, D., Jones, S.N., Flavell, R.A., and Davis, R.J. 2000. Requirement of INK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870-874.
38. Tournier, C., Dong, C., Turner, T.K., Jones, S.N., Flavell, R.A., and Davis, R.J. 2001. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes & Dev. 15: 1419-1426.
39. Vecchi, A., Garlanda, C., Lampugnani, M.G., Resnati, M., Matteucci, C., Stoppacciaro, A., Schnurch, H., Risau, W., Ruco, L., Mantovani, A., et al. 1994. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur. J. Cell Biol. 63: 247-254.
40. Vogelstein, B., Lane, D., and Levine, A.J. 2000. Surfing the p53 network. Nature 408: 307-310.
41. Wu, C.W., Li, A.F., Chi, C.W., Huang, C.L., Shen, K.H., Liu, W.Y., and Lin, W. 2000. Human gastric cancer kinase profile and prognostic significance of MKK4 kinase. Am. J. Pathol. 156: 2007-2015.
42. Yamada, S.D., Hickson, J.A., Hrobowski, Y., Vander Griend, D.J., Benson, D., Montag, A., Karrison, T., Huo, D., Rutgers, J., Adams, S., et al. 2002. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Res. 62: 6717-6723.
43. Yang, D., Tournier, C., Wysk, M., Lu, H.T., Xu, J., Davis, R.J., and Flavell, R.A. 1997a. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc. Natl. Acad. Sci. 94: 3004-3009.
44. Yang, D.D., Kuan, C.Y., Whitmarsh, A.J., Rincon, M., Zheng, T.S., Davis, R.J., Rakic, P., and Flavell, R.A. 1997b. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389: 865-870.
45. Yoshida, B.A., Dubauskas, Z., Chekmareva, M.A., Christiano, T.R., Stadler, W.M., and Rinker-Schaeffer, C.W. 1999. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res. 59: 5483-5487.
46. Yoshida, S., Fukino, K., Harada, H., Nagai, H., Imoto, I., Inazawa, J., Takahashi, H., Teramoto, A., and Emi, M. 2001. The c-Jun NH2-terminal kinase3 (JNK3) gene: Genomic structure, chromosomal assignment, and loss of expression in brain tumors. J. Hum. Genet. 46: 182-187.
47. Yu, J., Zhang, L., Hwang, P.M., Kinzler, K.W., and Vogelstein, B. 2001. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell 7: 673-682.
48. Zindy, F., Eischen, C.M., Randle, D.H., Kamijo, T., Cleveland, J.L., Sherr, C.J., and Roussel, M.F. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes & Dev. 12: 2424-2433.
49. Zong, W.X., Lindsten, T., Ross, A.J., MacGregor, G.R., and Thompson, C.B. 2001. BH3-only proteins that bind prosurvival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes & Dev. 15: 1481-1486.